Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03072602 · ClinicalTrials.gov registry record · NA
Racial Differences in the Natriuretic Peptide Response to Glucose Challenge
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT03072602 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 81 participants.
The verdict
NCT03072602, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of the study is to discover any racial dissimilarity in the response of Natriuretic peptide (NP) system to acute metabolic influences such as a high carbohydrate challenge
Interventions
- DIETARY_SUPPLEMENT Study diet
- OTHER Glucose Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03072602
The ClinicalTrials.gov registry entry for NCT03072602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Study diet is the first listed.
NCT03072602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03072602 about?
NCT03072602 is a clinical study titled "Racial Differences in the Natriuretic Peptide Response to Glucose Challenge". The purpose of the study is to discover any racial dissimilarity in the response of Natriuretic peptide (NP) system to acute metabolic influences such as a high carbohydrate challenge
What is the current status of trial NCT03072602?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2017-03-01. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT03072602?
The interventions under investigation include: Study diet (DIETARY_SUPPLEMENT), Glucose Challenge (OTHER).
Who is sponsoring clinical trial NCT03072602?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.